• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Normal Forgetfulness vs. Pre-Dementia: How to Distinguish Them

Normal Forgetfulness vs. Pre-Dementia: How to Distinguish Them

May 1, 2007
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD

A 70-year old man comes into your office and asks: “Doctor, I keep misplacing my keys-am I getting Alzheimer’s?” You detect the note of anxiety in his voice, and you want to give an answer, and soon.

Here is a reasonable approach, based on the latest research data.

First, rule out dementia.

If you haven’t reviewed them lately, the DSM-4 criteria for dementia are actually more stringent than you might recall.Your patient must meet the following three criteria:

1. Significant memory impairment. This is most easily tested by asking them to recall the date, and to perform a simple delayed recall task, such as repeating and then remembering three unrelated words after two minutes of delay. If family is present, ask them whether they’ve noticed a significant decline in the patient’s memory over the last few years; it’s probably as reliable as any office-based testing you can do, according to at least one study (Harwood et al., Age and Ageing 1997;26:31-35). Ask specifically if they have noticed the patient asking the same question or telling the same story repeatedly.

2. At least one of the following:

  • Apraxia. Ask: “Have you had problems doing simple everyday tasks, like getting dressed, balancing a checkbook, driving, and preparing meals?” Asking whether there have been problems using the TV or DVD remotes is even more sensitive but may well lead to false positives!

  • Agnosia. Ask: “Have you had problems recognizing people whom you really know?”

  • Executive functioning impairment. Ask: “Have you had problems planning things and getting them done, like cooking a meal or a gardening project?”  You can also have patients do the clock-drawing task: “Draw a clock on this page and draw in the hands to show ‘ten after eleven.’”

  • Aphasia. Ask: “Have you been having real problems remembering the right word for things?” “Have you had trouble understanding what people are saying to you?”


3. The symptoms must significantly impair everyday functioning. The best way to ascertain this is by asking if the patient has been requiring someone else’s help in performing a basic activity of daily living. Ask: “Have your memory problems made it necessary for you to get help with anything, like shopping, balancing your checkbook, cooking, or driving?”

Second, rule out mild cognitive impairment.

Let’s assume that your quick dementia screen was negative. Most elderly patients with subjective memory complaints who do not have dementia generally fit into one of the following two diagnostic categories: Age Associated Memory Impairment (AAMI) or Mild Cognitive Impairment (MCI). (I am assuming, of course, that you have already considered other common causes of memory impairment, such as depression, anxiety, medication side effects, substance abuse, and medical illness.)

You and your patient both hope that the problem is AAMI, otherwise known as “benign senescent forgetfulness,” and defined as the normal memory decline of aging. The key citerion is memory decline that is quite mild, not even close to causing functional impairment. Formal memory tests would show a memory below normal for a 25 year old, rather than below normal for your patient’s age. Clinically, AAMI presents with minor memory lapses, such as briefly forgetting someone’s name, or misplacing the car keys more often than in the past. Patients with AAMI probably do not progress to dementia any faster than the baseline rate (see the following good recent review of memory impairment for a discussion of AAMI: Feldman HH et al, Am J Geriatr Psychiatry 2005;13:645-655).

Mild Cognitive Impairment (MCI), on the other hand, is not so benign. Patients with MCI progress to dementia at a rate of 10-15% per year, vs. a 1-2% per year rate among normal elderly. How do you diagnose it? While there are different subcategories of MCI, the most common subtype is amnestic MCI, for which the Mayo Clinic recommends the following diagnostic criteria: (1) a subjective memory complaint, (2) normal activities of daily living, (3) normal general cognitive function, (4) abnormal memory for age, and (5) not demented (see Petersen RC, Arch Neurol 1999;56:303-308). As you can see, the key criterion differentiating MCI from AAMI is #4: abnormal memory for age, usually defined as 1.5 standard deviations below average for age on elaborate research-based memory tests.

Practically speaking, a patient with MCI will describe memory problems that are “pretty” severe (a judgment call for you), but that don’t quite lead to the impaired functional status of a patient with dementia. In contrast, the patient with AAMI has a degree of absent-mindedness that is annoying but not even close to causing functional decline (see a recent article in Rosenberg PB et al., Am J Psychiatry 163(11):1884-1890 for more diagnostic tips).

Can MCI be treated?

Unfortunately, trials of various strategies to slow the progression of MCI to dementia have been disappointing. For example, the Alzheimer’s Disease Cooperative

Study (ADCS) randomized MCI patients to Aricept (10 mg QD), vitamin E (2000 IU/day) or placebo. Aricept slowed progression only during the first 12 months of the three year study--by the end of the study, all three groups had the same rate of progression to AD. Vitamin E showed no beneficial effect at any point in the study (Petersen RC et al., NEJM 2005; 352:2379- 2388). Other cholinesterase inhibitors have shown similarly lackluster results, and as mentioned elsewhere in this issue, galantamine led to a higher mortality rate than placebo in industry trials.

In the absence of good medication treatments, many geriatric psychiatrists will focus on lifestyle changes. Recent studies have suggested that physical exercise (Podewils LJ et al., Am J Epidemiol 2005;161:639-651) and mental stimulation (Ball K et al., JAMA 2002;288:2271-2281) can both enhance memory. And don’t forget to encourage your patients to pay frequent visits to their primary care physicians for management of hypertension and high cholesterol, both of which can lead to vascular dementia.

























Diagnostic Choices for Memory Impairment
  AAMI MCI-amnestic Dementia
Functional
impairment?
No No Yes
Degree of
memory loss
1 SD below norms
for a young person
1.5 SDs below
norm for age
More severe
than MCI

AAMI = Age-Associated Memory Impairment

MCI-amnestic = Mild Cognitive Impairment, amnestic type

TCPR Verdict:

AAMI: benign memory lapses; MCI: pre-dementia
General Psychiatry
KEYWORDS dementia
    www.thecarlatreport.com
    Issue Date: May 1, 2007
    SUBSCRIBE NOW
    Table Of Contents
    Medications for Dementia: An Update
    Normal Forgetfulness vs. Pre-Dementia: How to Distinguish Them
    Agitation and Depression in Older Patients
    Antidepressants shown ineffective for bipolar depression
    FDA orders consumer medication guides for stimulants
    The molecular mechanism of antipsychotic- induced weight gain is found
    TMS for the treatment of auditory hallucinations
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.